166 related articles for article (PubMed ID: 2826016)
1. Augmentation of human natural cytotoxic cell activity by leukotriene B4 mediated by enhanced effector-target cell binding and increased lytic efficiency.
Gagnon L; Girard M; Sullivan AK; Rola-Pleszczynski M
Cell Immunol; 1987 Dec; 110(2):243-52. PubMed ID: 2826016
[TBL] [Abstract][Full Text] [Related]
2. Effect of LTB4 on the inhibition of natural cytotoxic activity by PGE2.
Vaillier D; Daculsi R; Gualde N; Bezian JH
Cell Immunol; 1992 Jan; 139(1):248-58. PubMed ID: 1309490
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
4. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
6. Differential Contribution of BLT1 and BLT2 to Leukotriene B4-Induced Human NK Cell Cytotoxicity and Migration.
Wang M; Mostafa El-Maghraby N; Turcotte S; Rola-Pleszczynski M; Stankova J
Mediators Inflamm; 2015; 2015():389849. PubMed ID: 26696753
[TBL] [Abstract][Full Text] [Related]
7. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of LTB4 on human natural killer cell activity and T lymphocyte transformation.
Hall TJ; Brostoff J
Immunol Lett; 1985; 9(5):255-8. PubMed ID: 2987110
[TBL] [Abstract][Full Text] [Related]
9. Definition of a secondary target cell trigger during natural killer cell cytotoxicity: possible role of phospholipase A2.
Deem RL; Britvan LJ; Targan SR
Cell Immunol; 1987 Dec; 110(2):253-64. PubMed ID: 3690677
[TBL] [Abstract][Full Text] [Related]
10. Products of the lipoxygenase pathway in human natural killer cell cytotoxicity.
Rossi P; Lindgren JA; Kullman C; Jondal M
Cell Immunol; 1985 Jun; 93(1):1-8. PubMed ID: 2986854
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human natural killer cell activity by (14R,15S)-14,15-dihydroxy-5Z,8Z,10E,12E- icosatetraenoic acid.
Ramstedt U; Serhan CN; Lundberg U; Wigzell H; Samuelsson B
Proc Natl Acad Sci U S A; 1984 Nov; 81(22):6914-8. PubMed ID: 6095260
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes.
Stanková J; Gagnon N; Rola-Pleszczynski M
Immunology; 1992 Jun; 76(2):258-63. PubMed ID: 1321793
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by D-mannose.
Stutman O; Dien P; Wisun RE; Lattime EC
Proc Natl Acad Sci U S A; 1980 May; 77(5):2895-8. PubMed ID: 6930673
[TBL] [Abstract][Full Text] [Related]
15. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
17. The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis.
Werkmeister JA; Triglia T; Burns GF
Cell Immunol; 1985 Apr; 92(1):123-33. PubMed ID: 3865715
[TBL] [Abstract][Full Text] [Related]
18. Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells.
Cifone MG; Botti D; Festuccia C; Napolitano T; del Grosso E; Cavallo G; Chessa MA; Santoni A
Cell Immunol; 1993 May; 148(2):247-58. PubMed ID: 8388321
[TBL] [Abstract][Full Text] [Related]
19. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
Stanková J; Rola-Pleszczynski M
J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
[TBL] [Abstract][Full Text] [Related]
20. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
